Published in J Clin Invest on June 01, 1988
Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J Clin Invest (1989) 5.21
Anticandidal activity of major human salivary histatins. Infect Immun (1991) 1.79
Killing of Giardia lamblia by cryptdins and cationic neutrophil peptides. Infect Immun (1994) 1.78
Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect Immun (1993) 1.74
Effects of neutrophils and in vitro oxidants on survival and phenotypic switching of Candida albicans WO-1. Infect Immun (1990) 1.67
Cytokine and chemokine production by human oral and vaginal epithelial cells in response to Candida albicans. Infect Immun (2002) 1.61
Antimicrobial proteins of murine macrophages. Infect Immun (1993) 1.50
Antifungal peptides: novel therapeutic compounds against emerging pathogens. Antimicrob Agents Chemother (1999) 1.48
Innate immunity in the human female reproductive tract: endocrine regulation of endogenous antimicrobial protection against HIV and other sexually transmitted infections. Am J Reprod Immunol (2011) 1.40
In vitro activity of the antimicrobial peptides human and rabbit defensins and porcine leukocyte protegrin against Mycobacterium tuberculosis. Infect Immun (1996) 1.37
Mechanism of mammalian cell lysis mediated by peptide defensins. Evidence for an initial alteration of the plasma membrane. J Clin Invest (1991) 1.33
Candida albicans mutants deficient in respiration are resistant to the small cationic salivary antimicrobial peptide histatin 5. Antimicrob Agents Chemother (2000) 1.32
Activity of defensins from human neutrophilic granulocytes against Mycobacterium avium-Mycobacterium intracellulare. Infect Immun (1992) 1.32
The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species. Proc Natl Acad Sci U S A (2001) 1.30
Mechanism for candidacidal activity in macrophages activated by recombinant gamma interferon. Infect Immun (1991) 1.29
The cytoplasmic membrane is a primary target for the staphylocidal action of thrombin-induced platelet microbicidal protein. Infect Immun (1997) 1.27
Effects of histatin 5 and derived peptides on Candida albicans. Biochem J (2001) 1.26
Through the looking glass, mechanistic insights from enantiomeric human defensins. J Biol Chem (2009) 1.25
Staphylocidal action of thrombin-induced platelet microbicidal protein is influenced by microenvironment and target cell growth phase. Infect Immun (1996) 1.21
Characterization of a fish antimicrobial peptide: gene expression, subcellular localization, and spectrum of activity. Antimicrob Agents Chemother (2000) 1.19
Candidacidal activities of human lactoferrin peptides derived from the N terminus. Antimicrob Agents Chemother (2000) 1.16
Human beta-defensins kill Candida albicans in an energy-dependent and salt-sensitive manner without causing membrane disruption. Antimicrob Agents Chemother (2006) 1.16
Salivary histatin 5 and human neutrophil defensin 1 kill Candida albicans via shared pathways. Antimicrob Agents Chemother (2000) 1.16
In vitro sensitivity of oral, gram-negative, facultative bacteria to the bactericidal activity of human neutrophil defensins. Infect Immun (1990) 1.13
Microbicidal properties and cytocidal selectivity of rhesus macaque theta defensins. Antimicrob Agents Chemother (2007) 1.13
Evaluation of susceptibility of gram-positive and -negative bacteria to human defensins by using radial diffusion assay. Antimicrob Agents Chemother (1996) 1.11
Host defense peptides in wound healing. Mol Med (2008) 1.10
Potential role for a carbohydrate moiety in anti-Candida activity of human oral epithelial cells. Infect Immun (2001) 1.08
MUC7 20-Mer: investigation of antimicrobial activity, secondary structure, and possible mechanism of antifungal action. Antimicrob Agents Chemother (2003) 1.04
Modulation of in vitro fungicidal activity of human lactoferrin against Candida albicans by extracellular cation concentration and target cell metabolic activity. Antimicrob Agents Chemother (2004) 1.03
Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes. Infect Immun (2008) 1.03
Large-scale synthesis and functional elements for the antimicrobial activity of defensins. Biochem J (2000) 1.03
In vitro killing of oral Capnocytophaga by granule fractions of human neutrophils is associated with cathepsin G activity. J Clin Invest (1991) 1.01
Activity of protegrins against yeast-phase Candida albicans. Infect Immun (1998) 1.00
Antifungal activities of human beta-defensins HBD-1 to HBD-3 and their C-terminal analogs Phd1 to Phd3. Antimicrob Agents Chemother (2008) 0.99
Peptide-based Antifungal Therapies against Emerging Infections. Drugs Future (2010) 0.97
Deletion of the SSK1 response regulator gene in Candida albicans contributes to enhanced killing by human polymorphonuclear neutrophils. Infect Immun (2005) 0.95
Hepcidin: the missing link between hemochromatosis and infections. Infect Immun (2003) 0.94
Evolution of caprine and ovine beta-defensin genes. Immunogenetics (2005) 0.94
Small, anionic, and charge-neutralizing propeptide fragments of zymogens are antimicrobial. Antimicrob Agents Chemother (1997) 0.91
Molecular determinants for the interaction of human neutrophil alpha defensin 1 with its propeptide. J Mol Biol (2008) 0.89
The α-defensin salt-bridge induces backbone stability to facilitate folding and confer proteolytic resistance. Amino Acids (2012) 0.89
Fungicidal properties of defensin NP-1 and activity against Cryptococcus neoformans in vitro. Antimicrob Agents Chemother (1993) 0.87
Antimicrobial activities of squalamine mimics. Antimicrob Agents Chemother (1997) 0.86
Interferon-gamma activates the oxidative killing of Candida albicans by human granulocytes. Clin Exp Immunol (1993) 0.85
Differential killing of Actinobacillus actinomycetemcomitans and Capnocytophaga spp. by human neutrophil granule components. Infect Immun (1991) 0.84
Role of host-defence peptides in eye diseases. Cell Mol Life Sci (2011) 0.84
Development of disease-resistant marker-free tomato by R/RS site-specific recombination. Plant Cell Rep (2011) 0.81
Redundant contribution of myeloperoxidase-dependent systems to neutrophil-mediated killing of Escherichia coli. Infect Immun (1997) 0.81
Antimicrobial action of rabbit leukocyte CAP18(106-137). Antimicrob Agents Chemother (1997) 0.81
Comparative genomics and evolution of the alpha-defensin multigene family in primates. Mol Biol Evol (2010) 0.80
Regulation of fungal infection by a combination of amphotericin B and peptide 2, a lactoferrin peptide that activates neutrophils. Clin Diagn Lab Immunol (2004) 0.78
History of medical mycology in the united states. Clin Microbiol Rev (1996) 0.78
Chemical genomic screening of a Saccharomyces cerevisiae genomewide mutant collection reveals genes required for defense against four antimicrobial peptides derived from proteins found in human saliva. Antimicrob Agents Chemother (2012) 0.77
Low concentrations of human neutrophil peptide ameliorate experimental murine colitis. Int J Mol Med (2016) 0.75
Critical design aspects involved in the study of Paneth cells and the intestinal microbiota. Gut Microbes (2013) 0.75
Antifungal Activity against Filamentous Fungi of Ts1, a Multifunctional Toxin from Tityus serrulatus Scorpion Venom. Front Microbiol (2017) 0.75
Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest (1985) 8.63
Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection. J Clin Invest (1969) 7.61
Purification and antibacterial activity of antimicrobial peptides of rabbit granulocytes. Infect Immun (1984) 5.30
Cyanide-insensitive respiration. An alternative mitochondrial pathway. Subcell Biochem (1975) 5.02
Primary structures of three human neutrophil defensins. J Clin Invest (1985) 3.70
Primary structures of six antimicrobial peptides of rabbit peritoneal neutrophils. J Biol Chem (1985) 3.58
ANTIBACTERIAL PROPERTIES OF PROTAMINE AND HISTONE. Science (1942) 3.32
Oxidants from phagocytes: agents of defense and destruction. Blood (1984) 3.20
Direct inactivation of viruses by human granulocyte defensins. J Virol (1986) 3.00
Antibacterial activity of cationic proteins from human granulocytes. J Clin Invest (1975) 2.97
[Sequence analysis of melittin from tryptic and peptic degradation products]. Hoppe Seylers Z Physiol Chem (1967) 2.72
Nonoxidative fungicidal mechanisms of mammalian granulocytes: demonstration of components with candidacidal activity in human, rabbit, and guinea pig leukocytes. Infect Immun (1975) 2.68
Functional aspects of a second mechanism of candidacidal activity by human neutrophils. J Clin Invest (1972) 2.25
Biological properties of poly-alpha-amino acids. Adv Protein Chem (1959) 2.17
Porosity of the yeast cell wall and membrane. J Bacteriol (1974) 2.10
Mechanisms for the microbicidal activity of cationic proteins of human granulocytes. Infect Immun (1976) 2.05
Activity of rabbit leukocyte peptides against Candida albicans. Infect Immun (1985) 2.05
Nonoxidative antimicrobial reactions of leukocytes. Contemp Top Immunobiol (1984) 1.97
Probing the phagolysosomal environment of human macrophages with a Ca2+-responsive operon fusion in Yersinia pestis. Nature (1986) 1.95
Effect of iron on the bactericidal proteins from rabbit polymorphonuclear leukocytes. Nature (1970) 1.91
ACTION OF RIBONUCLEASE PREPARATIONS ON VIABLE YEAST CELLS AND SPHEROPLASTS. J Bacteriol (1965) 1.73
Chlorination of endogenous amines by isolated neutrophils. Ammonia-dependent bactericidal, cytotoxic, and cytolytic activities of the chloramines. J Biol Chem (1984) 1.69
Utilization of methionine-containing peptides and their derivatives by a methionine-requiring auxotroph of Saccharomyces cerevisiae. J Biol Chem (1974) 1.68
Fungicidal properties of a chymotrypsin-like cationic protein from human neutrophils: adsorption to Candida parapsilosis. Infect Immun (1977) 1.61
Defensin-rich dense granules of human neutrophils. Blood (1987) 1.59
Effect of some proteins on the yeast cell membrane. J Bacteriol (1967) 1.51
The alternate respiratory pathway of Candida albicans. Arch Microbiol (1978) 1.19
Ultraviolet micrography of penetration of exogenous cytochrome c into the yeast cell. J Bacteriol (1969) 1.13
Lytic action of lysozyme on Candida albicans. Mycopathol Mycol Appl (1970) 1.10
Heterogeneity of human neutrophil phagolysosomes: functional consequences for candidacidal activity. Blood (1984) 1.08
Peptide uptake in Candida albicans. J Gen Microbiol (1980) 1.01
The role of metabolic energy in the lethal action of basic proteins on Candida albicans. Can J Microbiol (1977) 1.01
Fungitoxicity of muramidase. Ultrastructural damage to Candida albicans. Lab Invest (1982) 1.00
Oxygen-dependent and oxygen-independent mechanisms of microbicidal activity of neutrophils. Immunol Lett (1985) 0.89
The porosity of the cell wall of Candida albicans. J Gen Microbiol (1980) 0.83
Effect of seminalplasmin, an antimicrobial protein from bovine semen, on growth and macromolecular synthesis in Candida albicans. Indian J Biochem Biophys (1985) 0.79
Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest (1985) 8.63
Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem (2000) 8.39
Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol (2000) 6.62
Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol (1993) 5.36
Purification and antibacterial activity of antimicrobial peptides of rabbit granulocytes. Infect Immun (1984) 5.30
Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J Clin Invest (1989) 5.21
An antimicrobial activity of cytolytic T cells mediated by granulysin. Science (1998) 5.02
A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins. Science (1999) 3.90
Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes. Proc Natl Acad Sci U S A (1990) 3.90
Production of beta-defensins by human airway epithelia. Proc Natl Acad Sci U S A (1998) 3.85
Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest (1998) 3.78
Primary structures of three human neutrophil defensins. J Clin Invest (1985) 3.70
Primary structures of six antimicrobial peptides of rabbit peritoneal neutrophils. J Biol Chem (1985) 3.58
Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol (1999) 3.39
The multifaceted Paneth cell. Cell Mol Life Sci (2002) 3.11
Antimicrobial peptides in mammalian and insect host defence. Curr Opin Immunol (1999) 3.05
Primary structures of MCP-1 and MCP-2, natural peptide antibiotics of rabbit lung macrophages. J Biol Chem (1983) 3.00
Direct inactivation of viruses by human granulocyte defensins. J Virol (1986) 3.00
A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol (1990) 2.98
Defensins. Eur J Haematol (1990) 2.88
Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. Science (1991) 2.71
Monocyte-chemotactic activity of defensins from human neutrophils. J Clin Invest (1989) 2.50
Defensins: endogenous antibiotic peptides of animal cells. Cell (1991) 2.45
Interactions between human defensins and lipid bilayers: evidence for formation of multimeric pores. Protein Sci (1994) 2.43
Structure, function, and membrane integration of defensins. Curr Opin Struct Biol (1995) 2.40
Cutting edge: IFN-inducible ELR- CXC chemokines display defensin-like antimicrobial activity. J Immunol (2001) 2.38
Antibacterial activity of microbicidal cationic proteins 1 and 2, natural peptide antibiotics of rabbit lung macrophages. Infect Immun (1983) 2.33
Concurrent assessment of inner and outer membrane permeabilization and bacteriolysis in E. coli by multiple-wavelength spectrophotometry. J Immunol Methods (1988) 2.31
Direct inactivation of viruses by MCP-1 and MCP-2, natural peptide antibiotics from rabbit leukocytes. J Virol (1985) 2.31
Characterization of defensin resistance phenotypes associated with mutations in the phoP virulence regulon of Salmonella typhimurium. Infect Immun (1990) 2.25
Defensins and other endogenous peptide antibiotics of vertebrates. J Leukoc Biol (1995) 2.25
Broad-spectrum antimicrobial activity of human intestinal defensin 5. Infect Immun (1997) 2.22
Purification, primary structure, and antimicrobial activities of a guinea pig neutrophil defensin. Infect Immun (1987) 2.16
Innate antimicrobial activity of nasal secretions. Infect Immun (1999) 2.13
Discovery of new human beta-defensins using a genomics-based approach. Gene (2001) 2.08
Extracellular release of antimicrobial defensins by human polymorphonuclear leukocytes. Infect Immun (1987) 2.07
Activity of rabbit leukocyte peptides against Candida albicans. Infect Immun (1985) 2.05
Paneth cell defensins: endogenous peptide components of intestinal host defense. FASEB J (1996) 2.03
In vitro tumor cell cytolysis mediated by peptide defensins of human and rabbit granulocytes. Blood (1986) 2.01
Structure and mapping of the human beta-defensin HBD-2 gene and its expression at sites of inflammation. Gene (1998) 1.99
Antimicrobial polypeptides of human neutrophils. Blood (1990) 1.98
The t(8;21) fusion product, AML-1-ETO, associates with C/EBP-alpha, inhibits C/EBP-alpha-dependent transcription, and blocks granulocytic differentiation. Mol Cell Biol (1998) 1.98
Purification and in vitro activities of rabbit platelet microbicidal proteins. Infect Immun (1997) 1.96
Mouse Paneth cell defensins: primary structures and antibacterial activities of numerous cryptdin isoforms. Infect Immun (1994) 1.93
Neutrophils and host defense. Ann Intern Med (1988) 1.92
Correlation of binding of rabbit granulocyte peptides to Candida albicans with candidacidal activity. Infect Immun (1985) 1.89
Neutrophil defensins: purification, characterization, and antimicrobial testing. Methods Enzymol (1994) 1.88
The human beta-defensin-1 and alpha-defensins are encoded by adjacent genes: two peptide families with differing disulfide topology share a common ancestry. Genomics (1997) 1.86
Localization of human intestinal defensin 5 in Paneth cell granules. Infect Immun (1997) 1.84
In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. J Infect Dis (1986) 1.84
Determinants of Staphylococcus aureus nasal carriage. Clin Diagn Lab Immunol (2001) 1.80
Killing of Giardia lamblia by cryptdins and cationic neutrophil peptides. Infect Immun (1994) 1.78
Sizing membrane pores in lipid vesicles by leakage of co-encapsulated markers: pore formation by melittin. Biophys J (1997) 1.76
Posttranslational processing of defensins in immature human myeloid cells. Blood (1992) 1.68
Bilayer interactions of indolicidin, a small antimicrobial peptide rich in tryptophan, proline, and basic amino acids. Biophys J (1997) 1.68
Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. J Immunol (1989) 1.64
Mechanism of target cytolysis by peptide defensins. Target cell metabolic activities, possibly involving endocytosis, are crucial for expression of cytotoxicity. J Immunol (1988) 1.64
Structure and diversity of the murine cryptdin gene family. Genomics (1994) 1.62
Microbicidal cationic proteins of rabbit alveolar macrophages: amino acid composition and functional attributes. Infect Immun (1981) 1.61
Isolation and characterization of human defensin cDNA clones. Proc Natl Acad Sci U S A (1988) 1.61
Defensin-rich dense granules of human neutrophils. Blood (1987) 1.59
Localized antimicrobial peptide expression in human gingiva. J Periodontal Res (2001) 1.58
Plasma defensin concentrations are elevated in patients with septicemia or bacterial meningitis. J Lab Clin Med (1993) 1.57
Defensins: a family of antimicrobial and cytotoxic peptides. Toxicology (1994) 1.53
Increased content of microbicidal cationic peptides in rabbit alveolar macrophages elicited by complete Freund adjuvant. Infect Immun (1981) 1.52
Antimicrobial activity of phagocyte granule proteins. Semin Respir Infect (1986) 1.49
Purification and antimicrobial properties of three defensins from rat neutrophils. Infect Immun (1989) 1.46
Defensins promote fusion and lysis of negatively charged membranes. Protein Sci (1993) 1.43
Purification and primary structure of murine cryptdin-1, a Paneth cell defensin. FEBS Lett (1992) 1.42
Defensins and innate host defence of the gastrointestinal tract. Gut (1999) 1.41
Porcine polymorphonuclear leukocytes generate extracellular microbicidal activity by elastase-mediated activation of secreted proprotegrins. Infect Immun (1997) 1.40
Inhibition of neutrophil elastase prevents cathelicidin activation and impairs clearance of bacteria from wounds. Blood (2001) 1.39
Granulysin, a T cell product, kills bacteria by altering membrane permeability. J Immunol (2000) 1.39
Human neutrophil-mediated nonoxidative antifungal activity against Cryptococcus neoformans. Infect Immun (2000) 1.38
Defensins are mitogenic for epithelial cells and fibroblasts. J Cell Physiol (1993) 1.35
Regulation of human beta-defensins by gastric epithelial cells in response to infection with Helicobacter pylori or stimulation with interleukin-1. Infect Immun (2000) 1.33
In human epidermis, beta-defensin 2 is packaged in lamellar bodies. Exp Mol Pathol (2003) 1.33